SCHEMBL9402340

SCHEMBL9402340

CCCCc1nnc(SCC2CCCCC2)n1Cc1ccc(-c2ccccc2C#N)cc1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.47
▸ ACHE P22303 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9402234 0.84 AGTR1 (0.58) —
SCHEMBL9402474 0.83 PPARG (0.55) PPARGACHE
SCHEMBL9402175 0.82 AGTR1 (0.48) —
SCHEMBL9402495 0.82 AGTR1 (0.51) —
SCHEMBL9402197 0.78 ALDH1A1 (0.51) —
SCHEMBL9448503 0.77 PPARG (0.57) PPARGACHE
SCHEMBL9142219 0.74 ACHE (0.51) PPARGACHE
SCHEMBL1893683 0.73 AGTR1 (0.54) PPARGACHE
SCHEMBL3459616 0.71 PPARG (0.59) PPARGACHE
SCHEMBL9197325 0.71 PPARG (0.88) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5336778-A Substituted triazoles as angiotensin II antagonists MERCK & CO., INC. (US) 1994-08-09 — — US disclosed
EP-0409332-A2 Substituted triazoles as angiotensin II antagonists MERCK & CO. INC. (US) 1991-01-23 — — EP disclosed
Send feedback